CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 743 enrolled
Drug / intervention
Preference Based Decision Aidother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02032550
NCT02032550N/ACompleted
CompareCT.gov

Treatment Preference and Patient Centered Prostate Cancer Care

University of Pennsylvania·interventional·Posted Jan 10, 2014·Updated Aug 4, 2020

In Brief

A clinical study evaluating Preference Based Decision Aid for Prostate Cancer. Completed, enrolled 743 participants across 3 sites.

Detailed Summary

The purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of treatment preferences, type of treatment received and their relationship with health related quality of life, satisfaction with care, decision regret, and psychological health of men with localized prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute, Corporal Michael J. Crescenz VA Medical Center, Fox Chase Cancer Center

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 10, 2014
Enrollment StartJun 1, 2013
Primary CompletionJan 26, 2018
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 12.5 years ago

Interventions

Preference Based Decision Aidother

The objective of the preference based decision aid is to assess the treatment preferences of prostate cancer patients. The investigators will analyze the association between preferences, treatment choice and objective and subjective outcomes. The preference based decision aid will lead to a values-based patient centered treatment decision making. This will ultimately improve clinical decision making, clinical policy process, enhance patient centered care and improve prostate cancer outcomes.